Preparation method of cariprazine

A technology of cariprazine and system, which is applied in the direction of organic chemistry, can solve the problems of unstable temperature, only 75-80%, process impurities, etc., achieve less route steps, increase yield and reaction speed, and simple process Effect

Active Publication Date: 2019-10-11
SHANGYU JINGXIN PHARMA +2
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] As can be seen from the above synthetic route, in the process of synthesizing cariprazine, the classic synthesis process has the following problems: it uses p-toluenesulfonyl chloride to produce genotoxic impurities (p-toluenesulfonate); intermediate SM01 p-piperazine The docking temperature needs to be above 80°C, otherwise the reaction is incomplete, and SM0

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of cariprazine
  • Preparation method of cariprazine
  • Preparation method of cariprazine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0044] Reagents: The reactants and catalysts used in the examples of the present invention are all chemically pure and can be used directly or simply purified as needed; the organic solvents are all analytically pure and can be used directly. Reagents were purchased from China Pharmaceutical (Group) Shanghai Chemical Reagent Company.

[0045] Detection instrument: high performance liquid chromatography Agilent HPLC-1260

[0046] Nuclear magnetic resonance instrument model: Bruker avance III 400

[0047] Embodiment 1 Preparation of formula III compound trans 2-(trans-4-(3,3-dimethylureido) cyclohexyl) acetyl chloride

[0048] Preparation of trans 2-(trans-4-(3,3-dimethylureido) cyclohexyl) ethyl acetate of compound of formula I

[0049] Take compound trans 2-(4-aminocyclohexyl) ethyl acetate 5.0g (0.032mol), add 50ml of dichloromethane, 30% sodium hydroxide solution 8.5g (2eq), add N,N-di Methylformyl chloride 6.9g (0.064mol), heat preservation at 30°C and stir for 5h, point...

Embodiment 5

[0059] Example 5 Formula V compound N'-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-di Preparation of methylurea

[0060] Formula IV compound 3-((trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)-2-oxoethyl)cyclohexyl)-1,1 - Preparation of dimethylurea

[0061] Take 8.15g (0.03mol) of 1-(2,3-dichlorophenyl)piperazine hydrochloride, add 50ml of dichloromethane, add 8.3g (3eq) of potassium carbonate, cool to 0°C in an ice bath, and slowly drop into A solution composed of 5.0 g of compound III (0.02 mol) and 20 ml of dichloromethane was controlled at 0-10°C, and after 0.5 h of dripping, the plate was spotted to confirm that the reaction was complete. Add 100 ml of water to the reaction system, add hydrochloric acid, and adjust The pH value of the aqueous phase was 3-4, stirred for 10 minutes, the organic phase was separated, dried, filtered, and spin-dried to obtain 8.2 g of the compound of formula IV, with a yield of 93.1%;

[0062] Take 5g (0.011mo...

Embodiment 6

[0063] The preparation of embodiment 6 formula V compound

[0064] The preparation of formula IV compound

[0065] Take 8.15g (0.03mol) of 1-(2,3-dichlorophenyl)piperazine hydrochloride, add 50ml of dichloromethane, add 6.1g (3eq) of triethylamine, cool to 0°C in an ice bath, slowly drop Add 5.0 g of compound III (0.02 mol) and 20 ml of dichloromethane solution, control the internal temperature at 0-10 ° C, spot the plate after 0.5 h after the drop, confirm that the reaction is complete, add 100 ml of water to the reaction system, add hydrochloric acid, Adjust the pH value of the water phase to 3-4, stir for 10 minutes, separate the organic phase, dry, filter, and spin dry to obtain 8.2 g of the compound of formula IV, with a yield of 93.1%;

[0066] Take 5g (0.011mol) of the compound of formula IV, add 50ml of diethyl ether, cool the system to about 0°C, slowly drop in 28ml of DIBAL-H (1M n-hexane), keep the reaction at 0°C for 5h, and control the reaction in TLC (developing...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a preparation method of cariprazine. The preparation method of the cariprazine includes that a trans-2-(trans-4-(3, 3-dimethylureido) cyclohexyl) derivative is enabled to reactwith 1-(2, 3-dichlorophenyl) piperazine or salt thereof in an acid-binding agent reaction condition, and then the cariprazine is generated in a reducing agent reaction condition. The preparation method of the cariprazine is few in a synthetic route, simple in technology and conformable to production requirements.

Description

technical field [0001] The invention relates to medicinal chemistry, in particular to a preparation method of cariprazine. Background technique [0002] The structural formula of Cariprazine is shown as the compound of formula A. It was jointly developed by Gedeon Richter Ltd and Forest Laboratories. It was first reported that it has a dopamine D3 / D2 partial agonist, and it has both preferential binding to D3R and DA partial agonists. It is used for the treatment of schizophrenia, mania, and severe depression. Its hydrochloride was listed in the United States as an anti-schizophrenia drug in 2015. The chemical name is trans-1-{4-[2-[ 4-(2,3-Dichlorophenyl)-piperazin-1-yl]ethyl]cyclohexyl}-3,3-dimethylurea hydrochloride. [0003] [0004] There are documents to disclose the cariprazine synthesis process route as follows: [0005] [0006] As can be seen from the above synthetic route, in the process of synthesizing cariprazine, the classic synthesis process has the fo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D295/135
CPCC07D295/135
Inventor 张敏郑飞
Owner SHANGYU JINGXIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap